News Room

Kintor Pharmaceutical Ltd, invested by Shanghai FTZ Fund, officially listed on HKEX

2020-05-22

On May 22, 2020, Kintor Pharmaceutical Ltd. (Stock Code: 9939.HK) invested by Shanghai FTZ Fund, has officially been listed on the main board of Hong Kong Stock Exchange(HKEX). Kintor was established in 2009, focusing on the development and industrialization of potential "best in class" and "first in class" innovative drugs, and is committed to becoming a leading enterprise in the research, development and commercialization.